BOOSTRIX

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug BOOSTRIX contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphtheria toxoid adsorbed
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
Read about Diphtheria toxoid
2 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
3 Purified pertussis toxoid (PT XD)
Read about Pertussis toxoid
4 Filamentous hemagglutinin (FHA)
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
5 Pertactin (69-KDA outer membrane protein-69K)
UNII 2QNL82089R - BORDETELLA PERTUSSIS
Read about Pertactin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BOOSTRIX Suspension for injection in pre-filled syringe Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07AJ52 Pertussis, purified antigen, combinations with toxoids J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AJ Pertussis vaccines
Discover more medicines within J07AJ52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 78-MBE-1116
Country: EE Ravimiamet Identifier(s): 1282799, 1282801, 1282812, 1282823, 1282834, 1282845, 1282856, 1282867, 1282878, 1282889
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 63684
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 005085, 005096
Country: FR Base de données publique des médicaments Identifier(s): 62404793
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 262677
Country: HK Department of Health Drug Office Identifier(s): 48297
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6404
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1008858, 1089092, 1089093, 1089094, 1089095, 1089096, 1089097, 1089098, 1089099, 1089100, 1089101, 1089102, 1089103, 1089104, 1089105, 1089106, 1091088
Country: MT Medicines Authority Identifier(s): MA170/00101, MA170/00104
Country: NL Z-Index G-Standaard Identifier(s): 14983842
Country: NL Z-Index G-Standaard, PRK Identifier(s): 167827
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11307
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100211343
Country: SG Health Sciences Authority Identifier(s): 11845P, 13187P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 7063161
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699522967568
Country: US FDA, National Drug Code Identifier(s): 50090-1377, 50090-1831, 58160-842
Country: ZA Health Products Regulatory Authority Identifier(s): 43/30.2/0526, 49/30.2/1042

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.